Hyunsoo Cho

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Natural Killer Cells

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Yu Ri Kim, Hyunsoo Cho, Soo Jeong Kim, Haerim Chung, Hye Won Kook, Ji Eun Jang, June-Won Cheong, Jin Seok Kim
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma. The oncologist 29 (6) (2024)
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Yu Ri Kim, Hyunsoo Cho, Soo Jeong Kim, Haerim Chung, Hye Won Kook, Ji Eun Jang, June-Won Cheong, Jin Seok Kim
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma. The oncologist 29 (6) (2024)
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Namsoo Kim, Yu Jeong Choi, Hyunsoo Cho, Ji Eun Jang, Seung Tae Lee, Jae-Woo Song, Jong Rak Choi, June-Won Cheong, Haerim Chung, Saeam Shin
NUP98 is Rearranged in 5.0% of Adult East-Asian AML Patients. Blood advances (2024)
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Yu Ri Kim, Hyunsoo Cho, Soo Jeong Kim, Haerim Chung, Hye Won Kook, Ji Eun Jang, June-Won Cheong, Jin Seok Kim
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma. The oncologist (2024)
Sojeong Kim, Haerim Chung, Jeong-Eun Kwak, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin, Hyunsoo Cho, Jin Seok Kim
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for immunotherapy of cancer 12 (1) (2024)
Yu Ri Kim, Hyunsoo Cho, Soo Jeong Kim, Haerim Chung, Hye Won Kook, Ji Eun Jang, June-Won Cheong, Jin Seok Kim
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma. The oncologist 29 (6) (2024)
Ji Eun Jang, Doh Yu Hwang, Ju-In Eom, June-Won Cheong, Hoi-Kyung Jeung, Hyunsoo Cho, Haerim Chung, Jin Seok Kim, Yoo Hong Min
DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation. Cancers 15 (3) (2023)
Ji Eun Jang, Doh Yu Hwang, Ju-In Eom, June-Won Cheong, Hoi-Kyung Jeung, Hyunsoo Cho, Haerim Chung, Jin Seok Kim, Yoo Hong Min
DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation. Cancers 15 (3) (2023)
Hyunsoo Cho, Saeam Shin, Haerim Chung, Ji Eun Jang, Yu Ri Kim, June-Won Cheong, Yoo Hong Min, Seung-Tae Lee, Jong Rak Choi, Jin Seok Kim
Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma. British journal of haematology 198 (3) (2022)
Hyunsoo Cho, Kyung Hwan Kim, Hoyoung Lee, Chang Gon Kim, Haerim Chung, Yoon Seok Choi, Su-Hyung Park, June-Won Cheong, Yoo Hong Min, Eui-Cheol Shin, Jin Seok Kim
Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Ko Eun Lee, Seunghan Mo, Hyo-Seol Lee, Mijeong Jeon, Je Seon Song, Hyung-Jun Choi, Hyunsoo Cho, Chung-Min Kang
Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth. International journal of molecular sciences 22 (15) (2021)
Minsuk Kwon, Chang Gon Kim, Hoyoung Lee, Hyunsoo Cho, Youngun Kim, Eung Chang Lee, Seong Jin Choi, Jung-Yun Lee, In-Ho Seo, Bjarne Bogen, Ik-Chan Song, Deog-Yeon Jo, Jin Seok Kim, Su-Hyung Park, Inhak Choi, Yoon Seok Choi, Eui-Cheol Shin
PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (7) (2020)
Seon Pyo Hong, Myung Jin Yang, Hyunsoo Cho, Intae Park, Hosung Bae, Kibaek Choe, Sang Heon Suh, Ralf H Adams, Kari Alitalo, Dae-Sik Lim, Gou Young Koh
Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi. Nature communications 11 (1) (2020)
Shin Young Hyun, Sang Hoon Han, Soo-Jeong Kim, Ji Eun Jang, Yundeok Kim, Hyunsoo Cho, Jung Yeon Lee, June-Won Cheong, Yoo Hong Min, Jae-Woo Song, Jin Seok Kim
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens. Journal of Korean medical science 31 (4) (2016)